JONES EVAN/ FA

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -18% 8.2% 15.1%
Success rate 13% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -81%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
JONES EVAN/ FA's trades of Veracyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-26 2025-11-25
US Veracyte Inc (VCYT)
PlS Planned sale
17,447 +8.0%
400.82
US$2,580,318 		17,447 +8.0% 400.82 US$2,580,318
2025-11-25 2025-11-25
US Veracyte Inc (VCYT)
PrS Proposed sale
38,721
121.50
US$3,434,673 		38,721 121.50 US$3,434,673
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
38,676 -19.0%
240.08
US$1,750,015 		38,676 -19.0% 240.08 US$1,750,015
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
24,296 -43.8%
45.73
US$1,110,990 		24,296 -43.8% 45.73 US$1,110,990
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
5,872 -9.6%
45.07
US$264,640 		5,872 -9.6% 45.07 US$264,640
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
10,837 -15.0%
43.80
US$474,702 		10,837 -15.0% 43.80 US$474,702
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
1,126 -1.5%
43.03
US$48,455 		1,126 -1.5% 43.03 US$48,455
2025-11-07 2025-11-05
US Veracyte Inc (VCYT)
PlS Planned sale
408 -0.6%
41.74
US$17,031 		408 -0.6% 41.74 US$17,031
2025-11-05 2025-11-05
US Veracyte Inc (VCYT)
PrS Proposed sale
43,196
46.04
US$1,988,744 		43,196 46.04 US$1,988,744
2024-09-23 2024-09-19
US Veracyte Inc (VCYT)
PlS Planned sale
5,173 -100.0%
35.23
US$182,263 		5,173 -100.0% 35.23 US$182,263
2024-08-14 2024-08-13
US Veracyte Inc (VCYT)
PlS Planned sale
912 -15.0%
32.77
US$29,884 		912 -15.0% 32.77 US$29,884
2024-08-14 2024-08-13
US Veracyte Inc (VCYT)
PlS Planned sale
22,407 -78.6%
32.36
US$725,026 		22,407 -78.6% 32.36 US$725,026
2024-08-14 2024-08-13
US Veracyte Inc (VCYT)
PlS Planned sale
3,869 -12.0%
31.19
US$120,655 		3,869 -12.0% 31.19 US$120,655
2024-08-14 2024-08-13
US Veracyte Inc (VCYT)
PlS Planned sale
688 -2.0%
32.77
US$22,544 		688 -2.0% 32.77 US$22,544
2024-08-14 2024-08-13
US Veracyte Inc (VCYT)
PlS Planned sale
16,838 -32.5%
32.36
US$544,851 		16,838 -32.5% 32.36 US$544,851
2024-08-14 2024-08-13
US Veracyte Inc (VCYT)
PlS Planned sale
2,931 -5.3%
31.19
US$91,406 		2,931 -5.3% 31.19 US$91,406
2024-08-14 2024-08-12
US Veracyte Inc (VCYT)
PlS Planned sale
101 -0.3%
30.01
US$3,031 		101 -0.3% 30.01 US$3,031
2024-08-14 2024-08-12
US Veracyte Inc (VCYT)
PlS Planned sale
99 -0.2%
30.01
US$2,971 		99 -0.2% 30.01 US$2,971
2024-08-13 2024-08-09
US Veracyte Inc (VCYT)
PlS Planned sale
746 -2.2%
30.03
US$22,402 		746 -2.2% 30.03 US$22,402
2024-08-13 2024-08-09
US Veracyte Inc (VCYT)
PlS Planned sale
1,032 -2.2%
30.03
US$30,990 		1,032 -2.2% 30.03 US$30,990
2024-08-09 2024-08-07
US Veracyte Inc (VCYT)
PlS Planned sale
5,108 -10.2%
30.32
US$154,883 		5,108 -10.2% 30.32 US$154,883
2024-08-07 2024-08-07
US Veracyte Inc (VCYT)
PrS Proposed sale
59,904
27.05
US$1,620,403 		59,904 27.05 US$1,620,403
2024-03-05 2024-03-01
US Veracyte Inc (VCYT)
S Sale
10,000 -21.0%
24.36
US$243,599 		10,000 -21.0% 24.36 US$243,599
2024-03-01 2024-03-01
US Veracyte Inc (VCYT)
PrS Proposed sale
10,000
24.00
US$240,000 		10,000 24.00 US$240,000
2023-07-24 2023-07-19
US Veracyte Inc (VCYT)
PlS Planned sale
3,090 -8.1%
30.17
US$93,232 		3,090 -8.1% 30.17 US$93,232
2023-07-24 2023-07-19
US Veracyte Inc (VCYT)
PlS Planned sale
838 -2.2%
30.14
US$25,257 		838 -2.2% 30.14 US$25,257
2023-07-19 2023-07-19
US Veracyte Inc (VCYT)
PrS Proposed sale
3,090
29.28
US$90,475 		3,090 29.28 US$90,475
2023-07-19 2023-07-19
US Veracyte Inc (VCYT)
PrS Proposed sale
838
29.28
US$24,537 		838 29.28 US$24,537
2023-07-19 2023-07-18
US Veracyte Inc (VCYT)
PlS Planned sale
7,441 -16.3%
30.19
US$224,616 		7,441 -16.3% 30.19 US$224,616
2023-07-19 2023-07-18
US Veracyte Inc (VCYT)
PlS Planned sale
2,324 -5.7%
30.16
US$70,090 		2,324 -5.7% 30.16 US$70,090
2023-07-18 2023-07-18
US Veracyte Inc (VCYT)
PrS Proposed sale
7,441
29.78
US$221,593 		7,441 29.78 US$221,593
2023-07-18 2023-07-18
US Veracyte Inc (VCYT)
PrS Proposed sale
2,324
29.78
US$69,209 		2,324 29.78 US$69,209
2023-07-19 2023-07-17
US Veracyte Inc (VCYT)
PlS Planned sale
23,949 -34.4%
30.07
US$720,106 		23,949 -34.4% 30.07 US$720,106
2023-07-19 2023-07-17
US Veracyte Inc (VCYT)
PlS Planned sale
19,095 -31.9%
30.07
US$574,106 		19,095 -31.9% 30.07 US$574,106
2023-07-17 2023-07-17
US Veracyte Inc (VCYT)
PrS Proposed sale
23,949
29.92
US$716,554 		23,949 29.92 US$716,554
2023-07-17 2023-07-17
US Veracyte Inc (VCYT)
PrS Proposed sale
19,095
29.92
US$571,322 		19,095 29.92 US$571,322
2022-12-16 2022-12-14
US Veracyte Inc (VCYT)
PlS Planned sale
600 -1.2%
30.13
US$18,080 		600 -1.2% 30.13 US$18,080
2022-12-15 2022-12-13
US Veracyte Inc (VCYT)
PlS Planned sale
300 -0.6%
31.65
US$9,494 		300 -0.6% 31.65 US$9,494
2022-12-15 2022-12-13
US Veracyte Inc (VCYT)
PlS Planned sale
1,367 -2.6%
30.51
US$41,703 		1,367 -2.6% 30.51 US$41,703
2022-11-15 2022-11-11
US Veracyte Inc (VCYT)
PlS Planned sale
100 -0.2%
31.02
US$3,102 		100 -0.2% 31.02 US$3,102
2022-11-15 2022-11-11
US Veracyte Inc (VCYT)
PlS Planned sale
5,900 -10.1%
30.21
US$178,255 		5,900 -10.1% 30.21 US$178,255
2020-10-29 2020-10-27
US OpGen Inc (OPGN)
S Sale
1,748 -7.4%
2.35
US$4,108 		1,748 -7.4% 2.35 US$4,108
2020-09-09 2020-09-04
US OpGen Inc (OPGN)
S Sale
3,612 -13.3%
2.19
US$7,910 		3,612 -13.3% 2.19 US$7,910
2020-08-04 2020-08-03
US Veracyte Inc (VCYT)
PlS Planned sale
1,200 -1.7%
35.60
US$42,714 		1,200 -1.7% 35.60 US$42,714
2020-08-04 2020-08-03
US Veracyte Inc (VCYT)
PlS Planned sale
18,800 -21.0%
35.13
US$660,403 		18,800 -21.0% 35.13 US$660,403